Xortx TherapeuticsXRTX
13F holders, Q4 2025 (December 31)6holders
3new positions
3sold out
$0.54avg. 13F price*
At the end of Q4 2025, 6 institutions reported holding Xortx Therapeutics Inc. (XRTX) in their 13F filings, unchanged from Q3 2025. 3 opened new positions and 3 sold out. The largest holders were DRW Securities, LLC ($109K), Two Sigma Securities, LLC ($7K) and Baader Bank Aktiengesellschaft ($5K).
- Company
- Xortx Therapeutics Inc.
- CUSIP
- 98420Q306
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $121K |
| Exits | 3 | $81K |
All 13F filers, Q3 2025 → Q4 2025: 229,828 shares bought and 100,147 shares sold, net +129,681 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| DRW Securities, LLC | 0.01% | New | 193,599 | $109K |
| Two Sigma Securities, LLC | 0.00% | New | 12,597 | $7K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 18,732 | $5K |
| Royal Bank of Canada | 0.00% | Add +1042.7% | 4,091 | $2K |
| UBS Group AG | 0.00% | Add +498.7% | 1,401 | $787 |
| Clearstead Advisors, LLC | 0.00% | No change | 277 | $156 |
"% of holder's portfolio" is XRTX's weight in each manager's 13F, not the share of Xortx Therapeutics Inc. the manager owns.